Anti-VEGF drugs are used for ocular diseases to reduce neovascularization, vascular leakage, and scar formation. Gain an overview of the current anti-VEGF medications available to clinicians today.
Learn the two fundamental principles of behavioral economics and how to apply them to ophthalmic practice management.
To decrease the risk of growth and potential metastasis, diagnosis between benign choroidal nevi and melanoma should be established early. Learn about the risk factors, identification, screening, and treatment.
In January 2022, the FDA approved Vabysmo, a first-of-its-kind bispecific antibody. Get an overview of this exciting medication along with insights from two top ophthalmologists.
Become versed in the typical and atypical ocular manifestations of COVID-19 to be better equipped to manage patients’ health conditions and guide them to a positive prognosis.
Distinguishing and diagnosing lesions represents a diagnostic challenge for eyecare providers. Expand your knowledge on the differential diagnoses and management of some of the more common pigmented lesions encountered on routine clinical examination.
Gain a working knowledge the diagnostic criteria, screening tools, and treatment options for retinoblastoma—the most common intraocular cancer amongst the pediatric population.
While there are many policy approaches to address this issue, this article focuses on three potential growth areas. Learn which stakeholders and areas within the healthcare system to target to help mitigate gaps in access to medical and surgical retina care.
Eyes On 2022 drew 5,600+ ECPs from around the globe December 3-5, 2021. We curated a selection of 9 sessions from our popular Ophthalmology Track for you to watch on your own time.
Learn about the emerging treatment options for AMD. Here are the new treatments—such as pipeline therapies, biosimilar alternatives, novel intravitreal agents, and sustained drug delivery systems—that will receive significant attention in the next year.
Imaging options in ophthalmology, particularly in retina, are continually expanding. Find out which less-common imaging devices could best benefit your practice and improve patient outcomes.
iOCT provides additional information, which often translates to altered decision making by the surgeon. Learn how this emerging technology not only improves cost efficiency through reducing unnecessary surgical steps, but can lead to safer and more precise procedures.
With myopia set to drastically increase, eyecare professionals must be aware of prevalence, risk factors, pathology, and prevention to provide patients with appropriate counseling and care. Here are some of the latest findings.
The OHTS 20-year follow-up supports the standard of care of using topical ocular hypotensive medications to prevent glaucoma progression in moderate and high-risk patients with ocular hypertension.
It’s more important than ever for ophthalmologists to understand how their front-line colleagues approach glaucoma. Download the report to see how 667 optometrists diagnose, treat, and manage this condition.
In the past three decades, there have been major advancements in the diagnosis and treatment of inherited retinal diseases, including novel gene therapies. Here's what ophthalmologists should know about these new treatment options.
Diabetic eye disease remains a major cause of vision loss in patients with diabetes. Here, we present the role of corticosteroids in suppressing chronic inflammation and tissue injury specific to DME in the diabetic patient population.
In this short course, we highlight the important variables to consider before, during, and after surgery for diabetic retinopathy.
Uveitis, a term used to describe inflammation inside the eye, is often one of the more challenging diagnostic and treatment areas encountered by ophthalmology residents and fellows. In this course, learn the modern framework for uveitis diagnosis and treatment, including clinical pearls for differential diagnosis.
With the development of new tools for the diagnosis and management of diabetic retinopathy, it's worth returning to the evolution of the Early Treatment Diabetic Retinopathy Study (ETDRS) classification system in order to understand how ophthalmologists assess and grade diabetic retinopathy now.
Pentosan polysulfate sodium (PPS) (Elmiron; Janssen Pharmaceuticals) received Federal Drug Administration approval for the treatment of interstitial cystitis in 1996. Recently, reports have surfaced of maculopathy secondary to PPS. Here, we described a case of maculopathy secondary to PPS mimicking pattern dystrophy.
In this fascinating case of simultaneous bilateral CRAO in the absence of commonly associated settings, we discuss the patient's risk factors and symptoms, as well as how to plan for similar cases.
Apremilast was approved for managing oral ulcers associated with BD in 2019. Here, we describe a case with recurrent unilateral uveitis associated with BD that was successfully managed by apremilast.
When it comes to retinal detachment repair, scleral buckling is a classic. In this set of videos, three experienced surgeons walk you through their approaches to the procedure.
Retinal detachment is an urgent diagnosis and, without timely intervention, there is significant risk of permanent vision loss. Here's what ophthalmology residents need to know.
Infectious endophthalmitis is a serious vision-threatening condition. This course reviews current trends in etiology, causative microorganisms, management and evolving surgical techniques to address this condition.